Phase I study using pulverized curcumin for pancreatic/biliary tract cancer patients who get resistant to gemcitabine-based chemotherapy
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2013
At a glance
- Drugs Curcumin (Primary)
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions
- 03 Aug 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 22 May 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 07 Feb 2011 New trial record